KLRD1 and cancer: Proposals by academia, such as identifying allogeneic NK cells as one of the most effective cancer treatment options, have not made much progress in identifying a cancer therapy applicable to a majority of cancers without issues such as NK cell receptor downregulation.305 In my opinion, leaving these studies the academia and biotech companies would not bring a solution any time soon.